Johnson & Johnson
Key numbers
What the whole company is worth on the stock market.
Price ÷ last year's profit per share. Higher means investors pay more for each $1 of profit.
The same ratio using next year's expected profit.
How much the stock swings compared with the market: 1 moves like the market, 1.5 moves 50% more.
Yearly dividend as a share of the price.
What analysts say
23 analysts
Recent analyst actions
Financial health
Nine checks of profitability, debt and efficiency. 7–9 strong, 4–6 average, 0–3 weak.
Profitability and debt
Short-term assets ÷ short-term debts. Below 1 means more due within a year than on hand.
Fair value (DCF model)
A discounted-cash-flow model: what future cash flows are worth today. It is a model, not a promise.
Compared with similar companies
The company next to its sector peers.
| Company | Price | P/E | P/B | Market value |
|---|---|---|---|---|
| LLYEli Lilly and Company | 1,212.61 | 41.7 | 38.3 | $1.11T |
| JNJJohnson & Johnson | 253.22 | 28.6 | 6.1 | $601.22B |
| ABBVAbbVie Inc. | 285.27 | 78.7 | 94.4 | $496.77B |
| MRKMerck & Company, Inc. | 148.02 | 112.6 | 5.0 | $357.28B |
| UNHUnitedHealth Group Incorporated | 390.20 | 23.9 | 3.2 | $337.65B |
| TMOThermo Fisher Scientific Inc | 674.38 | 35.1 | 4.1 | $244.85B |
| AMGNAmgen Inc. | 426.28 | 25.7 | 20.4 | $224.61B |
| ABTAbbott Laboratories | 102.62 | 32.6 | 4.2 | $177.12B |
| PFEPfizer, Inc. | 29.48 | 37.2 | 1.6 | $161.33B |
| BMYBristol-Myers Squibb Company | 58.90 | 12.5 | 5.9 | $116.02B |
| Sector average | 42.9 | 18.3 |
About the company
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies …
Data: Elcaro Core (Yahoo Finance, Binance, Treasury) · Information, not investment advice.